Stefan A. Verweij
Utrecht, UT 3503RG, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case-Control Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 29, 2026
A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.
Journal: European journal of epidemiology
Published: July 04, 2025
A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.
Journal: European journal of epidemiology
Published: July 04, 2025
Collecting behavioural data across countries during pandemics: Development of the COVID-19 Risk Assessment Tool.
Journal: Behavior research methods
Published: June 14, 2025
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: October 01, 2024
Learning from European regulator-initiated studies for regulatory decision making.
Journal: Drug discovery today
Published: January 24, 2024
Comment on: "The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022".
Journal: Applied health economics and health policy
Published: October 25, 2023
A Natural Language Processing Approach Towards Harmonized Communication of Uncertainties Identified During the European Medicine Authorization Process.
Journal: Clinical pharmacology and therapeutics
Published: October 06, 2023
Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?
Journal: Pharmacoepidemiology and drug safety
Published: August 02, 2023
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis.
Journal: BMJ open respiratory research
Published: February 17, 2023
Last Updated: 09/26/2026